ArticlebioRxiv : the preprint server for biology2025
T1-weighted fMRI in mouse visual cortex using an Iron Oxide Nanoparticle contrast agent and Ultrashort Echo Time (UTE) imaging at 9.4 T.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated byT2026
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to investigate the feasibility of using T1-weighted fMRI with an iron oxide nanoparticle contrast agent and Ultrashort Echo Time (UTE) imaging at 9.4T to measure functional hyperaemia in the mouse visual cortex. The goal is to capture positive signal changes in both the parenchyma and pial surface, and to test whether surface vessels respond during neuronal activation.
methodsThe study involved scanning of nine mice after administration of iron oxide-based superparamagnetic contrast agent (Molday ION) via the tail vein. Two functional imaging experiments were conducted: one to investigate the effect of echo time on the functional response, and another to characterize the impact of higher resolution on UTE functional contrast. Regions of interest (ROIs) were defined in the parenchyma and pial surface of the visual cortex.
resultsThe administration of the contrast agent produced a bright-blood signal in the vasculature in structural MRI when using a UTE acquisition. Positive signal changes were observed at the shortest echo time (0.164 ms) in both the parenchyma (0.2% +/- 0.08) and pial surface (0.2% +/- 0.1 %), providing evidence that UTE fMRI experiments can detect changes in both pial and parenchymal vessels. Measurements using longer echo times (≥1 ms) showed negative signal changes. Higher spatial resolution resulted in increased percent signal change at the pial surface, suggesting less partial volume effects and better delineation of surface vessels.
conclusionThe findings demonstrate that T1-weighted fMRI with UTE imaging and iron oxide nanoparticles captures positive signal changes across all vascular compartments, providing additional insights into the involvement of surface vessels during functional hyperemia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.